A JAPANESE drugmaker said it is investigating one death from kidney dysfunction potentially linked to health supplements recalled last week by the firm.
This came yesterday, a day after the company said it was aware of 26 cases of people being hospitalised in relation to the prescription-free tablets.
Already a subscriber? Log in
Get 20% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
